This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Robert S. Slaughter
Introduction
Robert S. Slaughter is a notable inventor based in Chatham, NJ (US). He has made significant contributions to the field of immunology through his research and inventions. His work primarily focuses on the development of peptides with immunosuppressant activity, which have important applications in medicine.
Latest Patents
One of Robert S. Slaughter's key patents is for the Scorpion peptide margatoxin, which is known for its immunosuppressant activity. This thirty-nine amino acid peptide, Margatoxin (MgTX), is purified from the venom of the scorpion Centruroides margaritatus. The gene encoding MgTX is constructed and expressed in E. coli, allowing for the production of recombinant MgTX. This peptide acts as a potent and selective inhibitor of a voltage-dependent K⁺ channel present in human lymphocytes. MgTX exhibits immunosuppressant activity with human T-lymphocytes, making it useful in treating autoimmune diseases and preventing the rejection of foreign organ transplants.
Career Highlights
Robert S. Slaughter is currently associated with Merck & Co., Inc., where he continues to advance his research in immunology. His work has led to the development of novel therapeutic strategies that leverage the unique properties of MgTX. With a focus on enhancing the efficacy of immunosuppressants, his contributions are paving the way for improved treatments in various medical fields.
Collaborations
Robert has collaborated with several esteemed colleagues, including Maria L. Garcia and Gloria C. Koo. These collaborations have enriched his research and expanded the potential applications of his inventions.
Conclusion
Robert S. Slaughter's innovative work in the field of immunology, particularly with the development of margatoxin, showcases the importance of scientific research in creating effective medical treatments. His contributions continue to have a lasting impact on the field and offer hope for advancements in immunosuppressive therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile